日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat ,Elena Garralda ,Vladimir Galvao ,Philippe A Cassier ,Carlos Gomez-Roca ,Iphigenie Korakis ,Peter Grell ,Aung Naing ,Patricia LoRusso ,Romana Mikyskova ,Nada Podzimkova ,Milan Reinis ,Kaissa Ouali ,Andreu Schoenenberger ,Joachim Kiemle-Kallee ,Sascha Tillmanns ,Richard Sachse ,Ulrich Moebius ,Radek Spisek ,David Bechard ,Lenka Palova Jelinkova ,Irena Adkins ,Aurelien Marabelle

Nanrilkefusp alfa (SOT101), an IL-15 receptor βγ superagonist, as a single agent or with anti-PD-1 in patients with advanced cancers

Nanrilkefusp alfa (SOT101) 是一种 IL-15 受体 βγ 超激动剂,可作为单药或与抗 PD-1 药物联合用于治疗晚期癌症患者。

Stephane Champiat,Elena Garralda,Vladimir Galvao,Philippe A Cassier,Carlos Gomez-Roca,Iphigenie Korakis,Peter Grell,Aung Naing,Patricia LoRusso,Romana Mikyskova,Nada Podzimkova,Milan Reinis,Kaissa Ouali,Andreu Schoenenberger,Joachim Kiemle-Kallee,Sascha Tillmanns,Richard Sachse,Ulrich Moebius,Radek Spisek,David Bechard,Lenka Palova Jelinkova,Irena Adkins,Aurelien Marabelle  0

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

新型 PD-1 靶向、活性优化的 IL-15 突变体 SOT201 以顺式作用提供优于 PD1-IL2v 的抗肿瘤活性

Matuskova Hana, Marasek Pavel, Mazhara Vladyslav, Simonova Ekaterina, Kosinova Lucie, Danek Petr, Danova Klara, Sajnerova Katerina, Malatova Iva, Hrabankova Klara, Greco Denise, Martinec Ondrej, Fabisik Matej, Podzimkova Nada, Hladikova Kamila, Behalova Katerina, Antosova Zuzana, Sirova Milada, Mikyskova Romana, Reinis Milan, Kovar Marek, Béchard David, Moebius Ulrich, Palova Jelinkova Lenka, Spisek Radek, Steegmaier Martin, Adkins Irena

Direct Oxidation of Glucose to Glucaric Acid Using Bimetallic AuPt/ZrO(2) Nanocatalysts

利用双金属AuPt/ZrO(2)纳米催化剂将葡萄糖直接氧化为葡萄糖二酸

Olszowka, Joanna Elzbieta; Selim, Abdul; Lavrič, Žan; Teržan, Janvit; Kroflič, Ana; Grilc, Miha; Likozar, Blaž; Kupčík, Jaroslav; de Prado, Esther; Plsek, Jan; Mikyskova, Eliska; Moravkova, Jaroslava; Huš, Matej; Vajda, Stefan

Cardiac miRNA expression during the development of chronic anthracycline-induced cardiomyopathy using an experimental rabbit model

使用实验兔模型研究慢性蒽环类药物诱发的心肌病发展过程中的心脏 miRNA 表达

Michaela Adamcova, Helena Parova, Olga Lencova-Popelova, Petra Kollarova-Brazdova, Ivana Baranova, Marcela Slavickova, Tereza Stverakova, Petra Sauer Mikyskova, Yvona Mazurova, Martin Sterba

Discovery of a 6-Aminobenzo[b]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic Activities.

发现一种 6-氨基苯并[b]噻吩 1,1-二氧化物衍生物 (K2071),具有信号转导和转录激活因子 3 抑制、抗有丝分裂和衰老治疗活性

Oleksak Patrik, Rysanek David, Vancurova Marketa, Vasicova Pavla, Urbancokova Alexandra, Novak Josef, Maurencova Dominika, Kashmel Pavel, Houserova Jana, Mikyskova Romana, Novotny Ondrej, Reinis Milan, Juda Pavel, Hons Miroslav, Kroupova Jirina, Sedlak David, Sulimenko Tetyana, Draber Pavel, Chlubnova Marketa, Nepovimova Eugenie, Kuca Kamil, Lisa Miroslav, Andrys Rudolf, Kobrlova Tereza, Soukup Ondrej, Janousek Jiri, Prchal Lukas, Bartek Jiri, Musilek Kamil, Hodny Zdenek

Type I interferon signaling in malignant blasts contributes to treatment efficacy in AML patients

恶性原始细胞中的 I 型干扰素信号有助于 AML 患者的治疗效果

Peter Holicek, Iva Truxova, Jana Rakova, Cyril Salek, Michal Hensler, Marek Kovar, Milan Reinis, Romana Mikyskova, Josef Pasulka, Sarka Vosahlikova, Hana Remesova, Iva Valentova, Daniel Lysak, Monika Holubova, Petr Kaspar, Jan Prochazka, Lenka Kasikova, Radek Spisek, Lorenzo Galluzzi, Jitka Fucikova

Chronic inflammation decreases HSC fitness by activating the druggable Jak/Stat3 signaling pathway

慢性炎症通过激活可用药物控制的 Jak/Stat3 信号通路降低 HSC 适应性

Srdjan Grusanovic, Petr Danek, Maria Kuzmina, Miroslava K Adamcova, Monika Burocziova, Romana Mikyskova, Karolina Vanickova, Sladjana Kosanovic, Jana Pokorna, Milan Reinis, Tomas Brdicka, Meritxell Alberich-Jorda

P847: BIOLOGICAL AND MOLECULAR CHARACTERIZATION OF IN SILICO IDENTIFIED PUTATIVE INHIBITORS OF PARASPECKLE ASSEMBLY WITH POTENTIAL ANTI-MULTIPLE MYELOMA ACTIVITY

P847:对计算机筛选出的具有潜在抗多发性骨髓瘤活性的副斑点组装假定抑制剂进行生物学和分子表征

Lai, Chi-Yu; Yeh, Kun-Yun; Lin, Chiu-Ya; Hsieh, Yang-Wen; Lai, Hsin-Hung; Chen, Jim-Ray; Hsu, Chia-Chun; Her, Guor Mour; Mishima, Kazuhiko; Tkahashi, Naoki; Suzuki, Tomonari; Mizuno, Reina; Shirahata, Mitsuaki; Gay, L; Rossi, M; Conti Nibali, M; Sciortino, T; Bello, L; Grusanovic, Srdjan; Burocziova, Monika; Danek, Petr; Kuzmina, Maria; Kari Adamcova, Miroslava; Mikyskova, Romana; Vanickova, Karolina; Kosanovic, Sladjana; Pokorna, Jana; Reinis, Milan; Brdicka, Tomas; Alberich-Jorda, Meritxell; Wijnen, Noa; Barneh, Farnaz; Meulendijks, Thomas; Klein, Kim; Duddebach, Ester; Cornel, Annelisa; Dautzenberg, Noël; Ashtiani, Minoo; Krippner-Heidenreich, Anja; Nierkens, Stefan; Heidenreich, Olaf; Kaspers, Gertjan; Traini, Valentina; Fabbiano, Giuseppina; Ronchetti, Domenica; Silvestris, Ilaria; Katia Favasuli, Vanessa; Erratico, Silvia; Giannandrea, Domenica; Laurenzi, Tommaso; Palazzolo, Luca; Torrente, Yvan; Chiaramonte, Raffaella; Eberini, Ivano; Bolli, Niccolò; Neri, Antonino; Taiana, Elisa

Selection of endogenous control and identification of significant microRNA deregulations in cervical cancer

宫颈癌中内源性控制的选择和显著 microRNA 失调的鉴定

T Stverakova, I Baranova, P Mikyskova, B Gajdosova, H Vosmikova, J Laco, V Palicka, H Parova